Abstract
Please check the hierarchy of the section headings and correct if necessary.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Pan C-C, Chen PC-H, Tsay S-H, Ho DM-T. Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma. A systemic immunohistochemical survey using tissue array technique. Appl Immunohistochem Mol Morphol. 2005;13:347–52.
Koehne de Gonzalez AK, Salomao MA, Lagana SM. Current concepts in the immunohistochemical evaluation of liver tumors. World J Hepatol. 2015;7(10):1403–11.
Lamps LW, Folpe AL. The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review. Adv Anat Pathol. 2003;10:39–43.
Chu PG, Ishizawa S, Wu E, Weiss LM. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol. 2002;26:978–88.
Fan Z, van de Rijn M, Montgomery K, Rouse RV. Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol. 2003;16(2):137–44.
Mac T, Chung F, Lin F, et al. Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma. Am J Clin Pathol. 2009;132:80–5.
Jeung JA, Coran J, Liu C, et al. Hepatocyte paraffin 1 as a biomarker for early diagnosis of Barrett esophagus. Am J Clin Pathol. 2012;137(1):111–20.
Borscheri N, Roessner A, Röcken C. Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Am J Surg Pathol. 2001;25:1297–303.
St Lagana SH, Bao F, et al. Hep Par-1 and Arginase immunohistochemistry in adenocarcinoma of the small intestine and ampullary region. Arch Pathol Lab Med. 2015;139:791–5.
Ordonez NG. Arginase-1 is a novel immunohistochemical marker of hepatocellular differentiation. Adv Anat Pathol. 2014;21(4):285–90.
Timek DT, Shi J, Liu H, Lin F. Arginase-1, Hep par-1 and glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens. Am J Clin Pathol. 2012;138(2):203–10.
Lagana SM, Salomao M, Remotti HE, et al. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma. Histopathology. 2015;66(4):598–602.
Fujikura K, Yamasaki T, Otani K, et al. BSEP and MDR3 useful immunohistochemical markers to discriminate hepatocellular carcinomas from intrahepatic cholangiocarcinomas and hepatoid carcinomas. Am J Surg Pathol. 2016;40:689–96.
Di Tommaso L, Destro A, Seok JY, et al. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol. 2009;50(4):746–54.
Lagana SM, Salomao M, Bao F, et al. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. Appl Immunohistochem Mol Morphol. 2013;21(2):170–6.
Surrey LF, Frank R, Zhang PJ, et al. TTF-1 and Napsin are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts. Continued caveats for utilization of immunohistochemistry panels. Am J Surg Pathol. 2014;38(2):224–7.
Gütgemann I, Haas S, Berg JP, et al. CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions. Virchows Arch. 2006;448:407–11.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Tuffaha, M.S.A., Guski, H., Kristiansen, G. (2018). Markers and Immunoprofile of Hepatobiliary Tumors. In: Immunohistochemistry in Tumor Diagnostics. Springer, Cham. https://doi.org/10.1007/978-3-319-53577-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-53577-7_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-53576-0
Online ISBN: 978-3-319-53577-7
eBook Packages: MedicineMedicine (R0)